Andion CH4 Renewables (“Andion”), a biogas developer and operator, has reached financial close on a c.€70 million financing facility to progress its short‑term development pipeline across Italy and the Nordic region.

The facility has been provided by Private Credit at Goldman Sachs Alternatives, marking a significant milestone in Andion’s ambition to become a leading European biomethane operator. Andion’s existing shareholders, led by the Equitix Next Generation Fund, have also made a material equity contribution as part of the transaction.

The European biogas and biomethane sector is entering a period of accelerated expansion, underpinned by REPowerEU, Fit for 55 and broader energy‑security priorities. Across Italy and Northern Europe, engineered biogas plants are increasingly recognised as critical infrastructure, enabling circular management of organic waste while delivering dispatchable, locally produced renewable gas. As investment momentum grows, high‑quality biogas platforms are establishing themselves as a resilient, long‑term asset class aligned with Europe’s net‑zero, resource‑efficiency and energy‑independence objectives.

Jonas Martin-Löf, CEO & Chairman of Andion: “This marks a significant realisation and commitment of a steadily growing biomethane industrial platform in the Italian and Swedish biomethane marketplace. Our partnership with Goldman Sachs Alternatives and Equitix, demonstrates a strong confidence – foremost in our team, but also in our technology, project development and our ability to deliver, own and operate biogas projects at scale.”

The transaction reflects Andion’s ability to attract leading long‑term investors and deliver engineered biogas infrastructure by combining technical know‑how, disciplined project development and strong commercial partnerships.

Christian Schaefer, Managing Director and Co‑Head of Climate Credit at Goldman Sachs Alternatives, commented: “We are excited to partner with Andion and contribute to the realisation of this strategic project with a bespoke project‑finance unitranche solution.”

Andion was advised by Carlingford and BNP Paribas as financial advisors, and by GSK Stockman and De Berti Jacchia as legal advisors on the transaction.